Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;47(7):736-45.
doi: 10.1038/ng.3315. Epub 2015 May 25.

Spatial Genomic Heterogeneity Within Localized, Multifocal Prostate Cancer

Affiliations

Spatial Genomic Heterogeneity Within Localized, Multifocal Prostate Cancer

Paul C Boutros et al. Nat Genet. .

Abstract

Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized, multifocal prostate cancer to delineate new oncogenes or tumor suppressors. We initially determined the copy number aberration (CNA) profiles of 74 patients with index tumors of Gleason score 7. Of these, 5 patients were subjected to whole-genome sequencing using DNA quantities achievable in diagnostic biopsies, with detailed spatial sampling of 23 distinct tumor regions to assess intraprostatic heterogeneity in focal genomics. Multifocal tumors are highly heterogeneous for single-nucleotide variants (SNVs), CNAs and genomic rearrangements. We identified and validated a new recurrent amplification of MYCL, which is associated with TP53 deletion and unique profiles of DNA damage and transcriptional dysregulation. Moreover, we demonstrate divergent tumor evolution in multifocal cancer and, in some cases, tumors of independent clonal origin. These data represent the first systematic relation of intraprostatic genomic heterogeneity to predicted clinical outcome and inform the development of novel biomarkers that reflect individual prognosis.

Comment in

Similar articles

See all similar articles

Cited by 138 articles

See all "Cited by" articles

References

    1. Eur Urol. 2013 Feb;63(2):347-53 - PubMed
    1. Nature. 2012 Sep 6;489(7414):91-100 - PubMed
    1. J Pathol. 1996 Nov;180(3):295-9 - PubMed
    1. Nature. 2011 Feb 10;470(7333):214-20 - PubMed
    1. BMJ. 2010 Sep 14;341:c4543 - PubMed

Publication types

Substances

Associated data

Feedback